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ABSTRACT
Objectives: 2 innovative concepts have lately been
developed to radically improve the care of patients with
advanced chronic conditions (PACC): early
identification of palliative care (PC) needs and the 3
end-of-life trajectories in chronic illnesses (acute,
intermittent and gradual dwindling). It is not clear (1)
what indicators work best for this early identification
and (2) if specific clinical indicators exist for each of
these trajectories. The objectives of this study are to
explore these 2 issues.
Setting: 3 primary care services, an acute care
hospital, an intermediate care centre and 4 nursing
homes in a mixed urban–rural district in Barcelona,
Spain.
Participants: 782 patients (61.5% women) with a
positive NECPAL CCOMS-ICO test, indicating they
might benefit from a PC approach.
Outcome measures: The characteristics and
distribution of the indicators of the NECPAL CCOMS-
ICO tool are analysed with respect to the 3 trajectories
and have been arranged by domain (functional,
nutritional and cognitive status, emotional problems,
geriatric syndromes, social vulnerability and others)
and according to their static (severity) and dynamic
(progression) properties.
Results: The common indicators associated with early
end-of-life identification are functional (44.3%) and
nutritional (30.7%) progression, emotional distress
(21.9%) and geriatric syndromes (15.7% delirium,
11.2% falls). The rest of the indicators showed
differences in the associations per illness trajectories
(p<0.05). 48.2% of the total cohort was identified as
advanced frailty patients with no advanced disease
criteria.
Conclusions: Dynamic indicators are present in the 3
trajectories and are especially useful to identify PACC
for a progressive PC approach purpose. Most of the
other indicators are typically associated with a specific
trajectory. These findings can help clinicians improve
the identification of patients for a palliative approach.
INTRODUCTION
Two concepts can be combined to illuminate
care provision for patients with advanced
chronic conditions (PACC): early identiﬁca-
tion of patients with palliative care (PC)
needs and, second, end-of-life trajectories
associated with advanced chronic illnesses.
This gives a conceptual framework to under-
stand the different characteristics of patients
from their early identiﬁcation for PC
onwards.
Strengths and limitations of this study
▪ This study innovatively explores the relationship
between end-of-life indicators used to identify
patients with advanced chronic conditions
(PACC) and the three archetypal end-of-life tra-
jectories: acute (typically cancer), intermittent
(typically organ failure) and gradual dwindling
(typically dementia or frailty).
▪ Analysing the characteristics of end-of-life indica-
tors allows us to know which indicators most
consistently identify patients for palliative care
(PC). It also provides data on the characteristics
that most commonly occur in each end-of-life
trajectory.
▪ The large number of identified PACC but with no
advanced disease criteria reveals that there is a
real and not previously well-described cohort of
people with advanced frailty and PC needs.
▪ These concepts are useful for clinical decision-
making, for policymakers in designing appropri-
ate health services, as well as giving researchers
a theoretical framework for future research.
▪ Study limitations include the heterogeneity in the
collection of variables due to the multiple
assessments from all healthcare system
resources and the number of missing data in
some variables.
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Early identification of patients with PC needs
The modern approach to the end-of-life divides this into
two transitions1 (ﬁgure 1). The ﬁrst one, frequently
some months or years before death, may constitute the
starting of the process of identiﬁcation of patients with
PC needs, due to the appearance and recognition of
some indicators or variables which make early identiﬁca-
tion easier. Throughout the article, we will refer to these
patients with advanced chronic diseases and conditions,
PC needs and limited life prognosis as ‘patients with
advanced chronic conditions’ (PACC). The second tran-
sition—or ‘the last days or weeks of patient’s life’—starts
when the terminal decline begins and corresponds to
the out-moded paradigm of very late PC provision.
Early identiﬁcation for PC has shown many beneﬁts: it
helps to clarify treatment preferences and goals of care,
improves quality of life and symptom control, reduces
distress, allows less aggressive care, lower spending, and
may even lengthen survival.2–4 Thus, to develop anticipa-
tory PC5 becomes crucial during this ﬁrst transition.
A certain degree of prognostic approach may be used
with caution in the care of individual patients, and
professionals still have difﬁculties ﬁnding unequivocal
prognostic variables.6 Prognosis will always imply a
degree of uncertainty,7 since end-of-life processes are
multifactorial and strictly individual at the same time.
Besides, the earlier we want to identify these
patients, the more difﬁcult it becomes to obtain certain
prognostic variables.8
Thus, although certain variables are broadly linked
with mortality risks, there is no single prognostic indica-
tor that identiﬁes all patients who will die soon.6 The
classic prognosis approach focused on advanced chronic
disease severity criteria has limitations: prognostic
disease-centred variables, when used in isolation, have
shown low prognostic capacity,9–14 particularly for geriat-
ric patients with multiple chronic conditions.6 Other
general factors have proved to be more reliable
end-of-life prognostic indicators than disease-centred
variables:15 functional,16–19 nutritional20–24 and cognitive
status;25 26 emotional problems;27 28 geriatric syndromes
such as delirium,29 30 dysphagia,31 pressure ulcers32 and
repetitive falls;33 symptoms such as dyspnoea34–36 and
anxiety;37 social vulnerability38–41 or use of resources.42–44
Thus, most screening tools for identiﬁcation of
patients with PC needs45—for example, the Prognostic
Indicator Guidance of the Gold Standards Framework
(PIG-GSF),46 the Supportive and Palliative Care
Indicators Tool (SPICT),47 the RADboud indicators for
PAlliative Care needs (RADPAC)48 and the NECesidades
PALiativas CCOMS-ICO tool (NECPAL CCOMS-ICO
tool)49–51—have incorporated these general conditions
from different domains in different degrees.
The evaluation of these variables—disease speciﬁc and
these other general factors—has also shown the need
for complementing the static status (severity) with an
assessment of dynamic progression of decline.8
End-of-life trajectories
In 2003, Lunney et al52 described three distinct illness
trajectories of functional decline at the end of life
(ﬁgure 1), illustrating the typical dynamic patterns of a
group of patients classiﬁed according to their main
chronic disease. The ﬁrst clinical trajectory, typically
associated to cancer, features a stable and/or low
decline phase broken up by a severe decline in the last
few weeks. The second features a gradual decline, with
acute episodes usually related to concomitant processes
and disease evolution and partial recovery; this trajectory
corresponds to patients with advanced organ diseases
such as heart, lung, renal and liver failure. Finally, the
third trajectory shows a progressive slow-pace decline,
typically related to dementia or frail patients.
Later, Murray et al53 highlighted the clinical implica-
tions of end-of-life trajectories by presenting trajectories
as a framework to help professionals and patients facing
the uncertainty of having an advanced chronic condi-
tion avoid a prognostic paralysis. First, these trajectories
may help clinicians to better plan care to meet their
patients’ changing needs and help patients and care-
givers to cope with their situation. Second, by pointing
out that different models of care may be necessary to
reﬂect and tackle patients’ different experiences and
needs. Third, by graphing dimensional end-of-life trajec-
tories, the different dimensions of need—physical,
social, psychological and spiritual—may be identiﬁed
and addressed.
Hypothesis and objectives
We hypothesise that there might be a common denom-
inator in the characteristics of some indicators that
would allow us to identify PACC at speciﬁc time points.
On the other hand, distinguishing features may also
exist in other indicators that support and develop the
conceptual model of end-of-life trajectories.
Learning from the characteristics and evolution of
these end-of-life indicators as the basis of the individual
situational diagnosis8––understood as the assessment to
determine patients’ health degree and (or possible)
closeness to end-of-life situation (ﬁgure 1)—can help
clinicians to manage uncertainty and make better clin-
ical decisions, according to patients’ values and prefer-
ences.54 In order to develop further knowledge on these
indicators, we analysed the characteristics and distribu-
tion of the indicators related to end of life in a cohort of
patients identiﬁed with the NECPAL CCOMS-ICO tool.
METHODS
Our methods, as extensively described elsewhere,51 are
reported according to the Strengthening the Reporting
of Observational Studies in Epidemiology (STROBE)
recommendations.55 This study was formally approved
by the ethical research committees of institutions
involved in its execution (2010/PREVOsona: P10/65
and EO65).
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Study design and setting
A cross-sectional study of patients identiﬁed in a previ-
ous population-based study was conducted.51 The study
was conducted in the Spanish district of Osona,
Barcelona, a mixed urban–rural district with a popula-
tion of 156 087 residents, 21.4% of whom are aged
>65 years, with an annual mortality rate of 8.81 per 1000
inhabitants. Three selected primary care services and an
acute care hospital, an intermediate care centre and
four nursing homes serving these primary care services
agreed to participate.
Eligibility criteria and participant selection
Case selection was undertaken from November 2010 to
October 2011. There were no exclusion criteria. Patient
recruitment was made using the NECPAL CCOMS-ICO
tool through the healthcare records and by interviews
with healthcare professionals (doctors and nurses).
‘NECPAL positive (+)’ patients were deﬁned as being
surprise-question56 answer ‘no’ (“I would not be sur-
prised if this patient were to die in the next 12 months”)
and having at least one subsequent positive category: (1)
category 1: choice, request or need of PC approach (has
the patient or the main caregiver requested palliative/
comfort treatments exclusively or suggests limitation of
therapeutic effort? Healthcare professionals consider
that the patient requires palliative care or palliative treat-
ment at this moment?); (2) category 2: general clinical
prognostic indicators of severity and progression, includ-
ing comorbidity and resource use (table 1) or (3) cat-
egory 3: disease-speciﬁc prognostic indicators (table 2).
Variables and sources of information
In the selected cohort, we evaluated the indicators
included in the NECPAL CCOMS-ICO tool, which were
retrieved, if available, from patient’s clinical records by
the investigator team or by clinical judgement after
interviewing healthcare professionals (including clinical
variables and need, demand and choice requests). In
order to reduce systematic error, all deﬁnitions, proce-
dures—including data collection—and measures were
standardised and followed according to the study opera-
tions manual.
Indicators were arranged by domain (functional,
nutritional and cognitive status, emotional problems,
geriatric syndromes, social vulnerability and others) and
according to their static (severity) and dynamic (pro-
gression) characteristics, for patients in each of the
three end-of-life trajectories associated with advanced
chronic illnesses.
Indicators and diseases
We evaluated the distribution of the indicators by classi-
fying persons according to the presence of severity and/
or progression criteria of the main disease (cancer,
chronic pulmonary disease, chronic heart disease,
serious chronic liver disease, serious chronic renal
disease, chronic neurological diseases and dementia).
We refer to the group of patients identiﬁed as being
NECPAL (+) without severity and/or disease progression
criteria as ‘advanced frailty patients without advanced
disease criteria’.
Indicators and end-of-life trajectories
We organised the illnesses according to the described
end-of-life trajectories: cancer, organ failure (including
lung, heart, hepatic and renal disease) and dementia. As
for neurologic diseases, we put together primary neuro-
degenerative/Alzheimer and neurodegenerative diseases
such as Parkinson and amyotrophic lateral sclerosis for
easier analysis purposes, given that their clinical evolu-
tion tends to be similar to dementia.
Statistical methods
Characteristics by domain were reported as averages
with SDs for continuous variables (Barthel, Charlson,
Figure 1 Key transitions and the
three end-of-life trajectories. Early
identification of palliative care
needs becomes the starting point
for transition 1. Situational
diagnosis refers to the evaluation
and assessment of patients that
allows healthcare professionals
determine patients’ health degree
(A, B, C, D or E) and identify
entrance to transition 2 (D) or last
days–hours situation, instead (E);
this situational diagnosis is
indispensable to establish the
objectives of care in this
progressive care model in a
decision-making process shared
by professionals, patients and
their families.
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unplanned admissions and age) or percentages for the
categorical variables. All indicators were calculated for
the entire sample and for each four categories of
patients: cancer, organ failure, dementia/chronic neuro-
logical diseases and advanced frailty. We compared the
proportions among the four groups using χ2 test for cat-
egorical variables. Differences for non-categorical vari-
ables were assessed using ANOVA tests.
Analyses were performed with the Statistical Package
for Social Sciences (SPSS), V.21.0. A two-sided p value
<0.05 was considered to indicate statistical signiﬁcance.
RESULTS
Participants
A total number of 782 NECPAL positive (+) patients
(38.5% men; 61.5% women; mean age: 80.89) were
recruited from different levels of the health system: 523
(66.9%) residents in the community, 154 (19.7%) in
nursing homes, 55 (7%) at the intermediate care centre
and 50 (6.4%) at the acute care hospital; this distribu-
tion of patients among the diverse settings is representa-
tive of the population prevalence of these patients.51 All
participants were allocated to one trajectory presented
severity and progression criteria for two concomitant
organs. The online supplementary appendix shows the
results for each individual disease.
Main results
Functional progression (31.5% loss ≥2 activities of daily
living (ADLs), 44.3% clinical perception) and nutritional
criteria (particularly clinical perception, 30.7%) were the
indicators most constantly associated with end-of-life
identiﬁcation in all patients (table 3). For the patients
with cancer, organ failure and advanced frailty, we could
not determine if there were cognitive progression criteria
(na), since this feature was only evaluated as a criterion
for advanced dementia. Emotional distress (21.9%) and
some geriatric syndromes (11.2% falls and 15.7% delir-
ium) were also present, but less frequently and without
statistically signiﬁcant differences among the four groups.
Generally, families perceived more palliative needs than
the patients and professionals.
The functional severity criteria, cognitive severity cri-
teria, some geriatric syndromes such as decubitus ulcers,
dysphagia and repetition infections, comorbidity, use of
resources, election criteria, demand and need of PC and
age and gender showed statistically signiﬁcant differ-
ences in the classiﬁcation per trajectories performed.
▸ Patients with advanced cancer rarely presented with
functional severity criteria (4.5%). For these patients,
the presence of nutritional progression criteria was
more common than in the other groups (clinical per-
ception: 63.2%). There was a high need of complex
care (35.1%), as well as demand and need of PC
from the patients (17.1%), relatives (39.5%) and pro-
fessionals (47.4%).
▸ Patients with advanced organ disease—all had main
disease severity and progression criteria—presented
less parameters of general severity and progression
than the rest of trajectories and a lower percentage of
Table 1 Category 2 of the NECPAL CCOMS-ICO tool: general indicators of severity and progression
Domain Severity Progression (in the last 6 months)
Functional markers Serious established functional dependence
(Barthel Score <25, ECOG >2 or Karnofsky Score
<50%)
Loss of two or more ADLs even though there is
adequate therapeutic intervention or clinical
perception of functional decline (sustained,
intense/severe, progressive, irreversible) not
related to concurrent conditions
Nutritional markers Serum albumin <2.5 g/dL, not related to acute
episodes of unbalance
Weight loss >10% or clinical perception of
nutritional decline (sustained, intense/severe,
progressive, irreversible) not related to concurrent
conditions
Cognitive Unable to dress, wash or eat without assistance
(GDS/FAST 6c), urinary and faecal incontinence
(GDS/FAST 6d–e) or unable to communicate
meaningfully—six or less intelligible words (GDS/
FAST 7)
Loss of two or more ADLs in the last 6 months,
despite adequate therapeutic intervention
(invaluable in hyperacute situation due to
concurrent processes) or difficulty swallowing, or
denial to eat, in patients who will not receive
enteral or parenteral nutrition
Emotional Presence of emotional distress with psychological symptoms (sustained, intense/severe, progressive)
not related to acute concurrent conditions
Geriatric syndromes
(in the last 6 months)
Persistent pressure ulcers (stages III–IV), recurrent infections (>1), delirium, persistent dysphagia, falls
(>2)
Comorbidity Charlson Index
Additional factors on
use of resources
▸ Two or more urgent (unplanned) hospital (or skilled nursing facilities) admissions due to chronic
disease in the last year
▸ Need of complex/intense continuing care, either at an institution or at home
ADL, activities of daily living; ECOG, Eastern Cooperative Oncology Group; GDS/FAST, Global Deterioration Scale/Functional Assessment
Staging.
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Table 2 Category 3 of the NECPAL CCOMS-ICO tool: disease-specific indicators
Cancer (one single criterion) ▸ Confirmed diagnosis of metastatic cancer who present low
response or contraindication of specific treatment, progressive
outbreak during treatment or metastatic affectation of vital
organs
▸ Significant functional deterioration (palliative performance
status <50%)
▸ Persistent, troublesome symptoms, despite optimal treatment of
underlying condition(s)
Chronic pulmonary disease (two or more criteria) ▸ Breathlessness at rest or on minimal exertion between
exacerbations
▸ Difficult physical or psychological symptoms despite optimal
tolerated therapy
▸ FEV1 <30% or criteria of restricted severe deficit: FVC <40%/
DLCO <40%
▸ Accomplishment of oxygen therapy at home criteria
▸ Recurrent hospital admissions (>3 admissions in 12 months
due to exacerbations)
Chronic heart disease (two or more criteria) ▸ Heart failure NYHA stage III or IV, severe valve disease or
inoperable coronary artery disease
▸ Shortness of breath at rest or minimal exertion
▸ Difficult physical or psychological symptoms despite optimal
tolerated therapy
▸ Ejection fraction severely affected (<30%) or severe pulmonary
hypertension (>60 mm Hg)
▸ Renal failure (GFR <30 L/min)
▸ Repeated hospital admissions with symptoms of heart failure/
ischaemic heart disease (>3 last year)
Serious chronic liver disease (one single criterion) ▸ Advanced cirrhosis: stage Child C, MELD-Na Score >30 or with
one or more of the following medical complications:
diuretic-resistant ascites, hepatorenal syndrome or upper
gastrointestinal bleeding due to portal hypertension with failed
response to treatment
▸ Hepatocellular carcinoma: present, in stage C or D (BCLC)
Serious chronic renal disease (one single criterion) ▸ Serious renal failures (GFR <15) in patients to whom
substitutive treatment or transplant is contraindicated
Chronic neurological diseases (1): CVA (one single
criterion)
▸ During acute and subacute phases (<3 months poststroke):
persistent vegetative or minimal conscious state >3 days
▸ During the chronic phase (>3 months poststroke): repeated
medical complications (aspiration pneumonia, pyelonephritis,
recurrent febrile episodes, pressure ulcers stages 3–4 or
dementia with severe criteria poststroke)
Chronic neurological diseases (2): motor neuron
diseases, multiple sclerosis and Parkinson (two or more
criteria)
▸ Progressive deterioration in physical and/or cognitive function
despite optimal therapy
▸ Complex and difficult symptoms
▸ Speech problems with increasing difficulty communicating
▸ Progressive dysphagia
▸ Recurrent aspiration pneumonia, breathless or respiratory
failure
Dementia (two or more of the following criteria) ▸ Severity criteria: GDS/FAST 6c or more.
▸ Progression criteria: loss of two or more ADLs in the last
6 months, despite adequate therapeutic intervention or difficulty
swallowing, or denial to eat, in patients who will not receive
enteral or parenteral nutrition
▸ Use of resources criteria: multiple admissions (>3 in 12 months,
due to concurrent processes—aspiration pneumonia,
pyelonephritis, sepsis, etc—that cause functional and/or
cognitive decline)
ADL, activities of daily living; BCLC, Barcelona clinic liver cancer; CVA, cerebrovascular accident; DLCO, diffusing capacity of the lung for
carbon monoxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; GFR, glomerular filtration rate; NYHA, New York Heart
Association.
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Table 3 Distribution of indicators per end-of-life trajectory
End of life trajectory
All patients Cancer
Organ failure
(pulmonary
+heart+liver
+renal)
Dementia
+chronic
neurological
diseases
Advanced
frailty
No advanced
disease
criteria
p Value
n=782 n=76 (9.7%) N=126 (16.1%) n=203 (26%) n=377 (48.2%)
Domain n % n % n % n % n %
Functional
S (Barthel <25) 147 22.2 3 4.5 6 5.3 101 49.7 37 10.6 <0.005
P (loss ≥2ADL’s) 243 31.5 33 43.4 38 30.6 63 31.03 109 29.4 0.121
P (clinical perception) 343 44.3 45 59.2 54 42.9 84 41.4 160 43 0.050
Nutritional
S (albumin <2.5) 24 5.8 5 8.1 6 6.4 1 0.4 13 5.9 0.560
P (Weight loss >10%) 42 12.2 7 23.3 6 11.5 14 6.8 15 9.7 0.211
P (clinical perception) 237 30.7 48 63.2 29 23 63 31.3 97 26.3 <0.005
Cognitive
S (GDS ≥6c) 169 21.9 0 0 0 0 169 83.2 0 0 <0.005
P (loss ≥2ADL’s) 68 8.7 na na na na 68 33.5 na na <0.005
Emotional
Distress 165 21.9 20 24.7 28 22.6 33 16.2 84 23.8 0.134
Geriatric syndromes
Pressure ulcers 34 4.4 3 4 1 0.8 19 9.3 11 3 <0.005
Dysphagia 81 10.4 8 10.8 4 3.2 48 23.6 21 5.6 <0.005
Falls >2 86 11.2 7 9.5 9 7.3 26 12.8 44 12 0.401
Delirium 122 15.7 10 13.2 17 13.5 38 18.7 57 15.3 0.518
Rec. infections 41 5.3 3 4 14 11.2 8 3.9 16 4.3 0.015
Others
Comorbidity (Charlson average) 3.23 (±2.9) 5.34 (±2.6) 3.38 (±2.1) 2.28 (±1.7) 3.07 (±2.2) <0.005
Use of resources
Unplanned admissions (average, per year) 0.55 (±1.0) 0.64 (±0.9) 1.0 (±1.3) 0.22 (±0.5) 0.5 (±1.15) <0.005
Complex care 145 19.2 26 35.1 27 22.1 28 13.8 64 17.9 <0.005
Palliative care approach
Choice/demand patient 44 5.6 13 17.1 7 5.6 3 1.4 21 5.6 <0.005
Choice/demand family 209 26.7 30 39.5 30 23.8 69 34.0 80 21.5 <0.005
Need (healthcare professionals) 121 15.5 36 47.4 21 16.9 27 13.3 37 10 <0.005
Age (mean) 80.89 (±11.9) 79.9 (±24.0) 77.7 (±13.4) 82.99 (±9.7) 82.6 (±11.3) <0.005
Sex
Male 301 38.5 44 57.9 66 52.4 50 24.6 141 37.4 <0.005
Women 481 61.5 32 42.1 60 47.6 153 75.4 236 62.6
%, Percentage of patients with the presence of the analysed variable with respect to the total of patients (once missing data excluded).
p Values: obtained from comparative analysis among the four groups described: cancer, organ failure, dementia/chronic neurological diseases in advanced frailty.
ADL, activities of daily living; n, number of valid patients for evaluation of variable; na, not applicable; P, progression criteria; S, severity criteria.
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geriatric syndromes. In contrast, they presented a
larger percentage of systemic infections (11.2%) and
more unplanned admissions than the other groups.
▸ Patients with advanced dementia and those with
chronic neurological diseases presented severity cri-
teria, functional (49.7%) and cognitive (83.2%), and
geriatric syndromes: ulcers (9.3%), persistent dyspha-
gia (23.6%), repetitive falls (12.8%) and delirium
(18.7%). These patients presented less need of
resources than the other groups, and there was a low
perception of palliative needs among the profes-
sionals (13.3%) compared to relatives (34%).
▸ 48.2% of the whole NECPAL(+) patients did not
present severity and progression criteria for any
chronic disease. In comparison with the other trajec-
tories, no indicator in this group (‘advanced frailty
patients with no advanced disease criteria’) was espe-
cially prevalent or relatively infrequent: for instance,
these patients present more functional severity cri-
teria (10.6%) than patients with cancer (4.5%) and
patients with organ failure (5.3%), but lower than
patients with dementia (49.7%); they present less
nutritional progression criteria (9.7%) than patients
with cancer (23.3%) and patients with organ failure
(11.5%), but more than patients with dementia
(6.8%) or they have more comorbidities (Charlson:
3.07) than patients with dementia (2.28), but less
than patients with cancer (5.34) and patients with
organ failure (3.38). Globally, professionals had low
perceptions that these patients had palliative needs.
DISCUSSION
Key results
Dynamic indicators are more discriminating than static
ones to identify PACC.19 Functional and nutritional pro-
gression criteria (also cognitive progression could be
included if there is delirium)57 are also important, mainly
regarding functional loss.58 59 This fact is supported by the
literature, given the evidence that changing variables have
been shown to have better prognostic ability than those vari-
ables that remain stable.19 58 59 Also emotional distress and
some geriatric syndromes, though less signiﬁcantly, have
been shown to be useful indicators for early identiﬁcation.
Beyond the described parameters, we consider that
there are no unique and speciﬁc indicators to reliably
identify PACC, since only a low percentage of patients
present most of them. This fact has two implications: (1)
early identiﬁcation of PACC requires a multidimensional
evaluation including a wide range of indicators and (2)
the different characteristics of these indicators in the
diverse groups (cancer, organ disease and dementia/
advanced neurologic disease) support the conceptual
model of end-of-life trajectories. This model seems to be
consistent beyond the described functional dimension:
in many of the other dimensions (nutritional, cognitive,
geriatric syndromes and use of resources), the behaviour
is also different among the groups.
Regarding the differences of the variables in the three
end-of-life trajectories, the low prevalence of patients
with advanced cancer and functional severity criteria is
remarkable; this could be due to a faster decline of
these patients in the second transition—if we assume
that most patients of this cohort were stable,60–62
although it could also be due to a selection bias on the
part of recruitment process. The impact of undernour-
ishment as an important marker of end of life in
patients with cancer is also consistent with the litera-
ture.63–66 For patients with advanced organ diseases,
there are more unplanned admissions, probably because
of episodes of acute failure or infections, in keeping
with the trajectory classically described cohort.44 52 67–74
As for patients with dementia or with other neurological
diseases the criteria of disease severity (frequently based
on the functional repercussions of the severity) deter-
mine the identiﬁcation of the end-of-life situation.75 76
This fact, together with the presence of multiple geriat-
ric syndromes, can help professionals in this process of
identiﬁcation.77 The slow and progressive process of
decline determines less use of resources and, probably,
less perception of PC needs from the professionals, in
contrast to the relatives’ view. This analysis endorses the
conceptual approach of typical trajectories of decline in
advanced chronic illnesses.
However, with mutimorbidity the norm at the end of
life, patients may embrace one or more trajectories.78 79
This resulted in an extremely heterogeneous behaviour
of the variables over time among different patients.
It was remarkable that in a particularly disease-centred
clinical context, practically half of the cohort did not
meet advanced disease criteria (‘advanced frailty
patients with no advanced disease criteria’), but were
identiﬁed as persons with advanced chronic conditions
and PC needs at the same time (NECPAL+); it is esti-
mated that 40% of deaths occur in frail older people
who have no main overriding diagnosis.80 This is rele-
vant because it suggests that for early identiﬁcation for
PC it is essential to look beyond disease-centred variables
and that multiple general indicators in different
domains need to be considered.81 Given that frailty is
the most prevalent condition as people approach
death,82 a rational clinical approach to these patients
would be to consider frailty not as an independent
entity deﬁning only one of the end-of-life trajectories,
but as a quantitative measurement system to determine
the reserve level of the patient. Such reserve would act
as the basis for a ‘situational diagnosis’. Analysis shows
that most variables are present in the end-of-life trajec-
tories, although they behave differently. It may be that
with frail patients, the other non-physical trajectories of
need may be important to monitor clinically, as they may
show more dynamic needs for care.83 More research will
be needed to substantiate this claim.
Finally, patients with cancer and patients without
cancer present physical decline and signiﬁcant psycho-
social difﬁculties, and all these patients could beneﬁt
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from a PC approach. However, healthcare professionals
currently identify less patients for a palliative approach
for the non-cancer group.84 This might be because the
end-of-life trajectory is less predictable for these patients,
but this should not stop identifying these patients
according to these indicators, rather than professionals
having a prognostic paralysis.85
Strengths and limitations
The study was carried out with 100% of participation
from healthcare professionals and settings invited. A
standardised case identiﬁcation methodology was fol-
lowed in all settings, and a high level of commitment
from all participants was gained.
The study has limitations. Since this study was based on
health professionals’ assessment and routine data, patients’
perspectives were not included. Availability of quantitative
data in clinical charts may have affected description of
patients’ characteristics. The study results may have also
been affected by the ageing population and strong inﬂu-
ence of geriatric care in the area, as well as by the length
of the study window. Additionally, a problem of over identi-
ﬁcation with the tool cannot be dismissed, due to the high
number of ‘advanced frailty patients with no advanced
disease criteria’. We are currently monitoring the mortality
of this cohort to conﬁrm or reject this hypothesis.
There was a signiﬁcant number of missing nutritional
indicators requiring an objective measure (47.2% due to
albumin or 56% due to weight loss)¾see online
supplementary appendix. This fact emphasises some dis-
cordance between the importance of measuring the nutri-
tional state according to scientiﬁc evidence20–23 and the
real clinical practice; we wonder whether using other para-
meters in the evaluation of undernourishment such as
body mass index or mini nutritional assessment86 results
would be indicated. Some of the indicators described in
the background section, such as social vulnerability or
symptoms, were not included in the NECPAL CCOMS-ICO
tool. Thus, these could not be assessed in the study; simi-
larly, the progression criteria for dementia could only be
assessed for patients with severity criteria of dementia.
The proposal of grouping neurologic diseases includ-
ing neurodegenerative diseases such as Parkinson and
amyotrophic lateral sclerosis with the group of primary
neurodegenerative/Alzheimer is arguable; however, it
might have not effected ﬁnal results, given the low
number of patients (n=31, 4% of the total cohort).
Generalisability and future trends
More studies are needed to corroborate these data.
However, the results described are a useful basis for
future research on the early identiﬁcation of PACC for
integrated PC. Suggested topics to be developed include
▸ The cohort corresponds to persons identiﬁed a priori
as PACC and likely to die in the foreseeable future. It
will be necessary, however, to analyse the behaviour of
these variables in relation to mortality. We are cur-
rently monitoring the cohort at 24 months.
▸ Given the large prevalence of advanced frailty
patients, new frameworks8 and tools87 based on
knowledge on geriatrics, primary care and PC are
indicated. In fact, these three areas already share
methods regarding care process:88 team work, multi-
dimensional assessment, patient-centred care, psycho-
social and caregivers support. More shared research
between these specialties and public health will best
take this agenda forward together.
▸ The conceptual link between the need of multidi-
mensional evaluation of PACC and the high preva-
lence of advanced frailty patients with no advanced
disease criteria can be found in the evaluation of the
level of reserve of these patients. Frailty indices,89–93
already proved to have a strong association with mor-
tality, may become the gold standard for situational
diagnosis, since they allow to quantify people’s health
reserves from a universal and objective point of view.
CONCLUSIONS
Learning from the behaviour of end-of-life indicators
helps clinicians deal with the clinical complexity and
innate prognostic uncertainties of this group of patients.
There are indicators of PC needs common to all types
of trajectories, and others associated with speciﬁc trajec-
tories: dynamic variables most consistently identify PACC
and PC needs, regardless of the patient’s end-of-life tra-
jectory. Additionally, the analysis of the other indicators
allows us to develop useful knowledge relating to how
people die in different ways. To explore in detail the
characteristics of the indicators in these patients will
help to provide them with patient-centred care.
Almost half of the cohort, although identiﬁed as
PACC, did not have severe or progression advanced
disease. This fact is particularly relevant and highlights
the need for more research, probably by using new
measuring systems for frailty, and the need of alternative
conceptual models, probably by deﬁning new end-of-life
trajectories, in order to provide better end-of-life care to
this great number of people.
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